What is Ozette?
Ozette operates at the intersection of biotechnology and computational analysis, aiming to accelerate the development of novel cancer drugs. Headquartered in Seattle, WA, the company leverages advanced data processing techniques to provide critical insights that aid researchers and pharmaceutical companies in their drug discovery pipelines. This focus positions Ozette as a key player in the competitive landscape of precision medicine and cancer therapeutics.
How much funding has Ozette raised?
Ozette has raised a total of $32M across 2 funding rounds:
Angel/Seed
$6M
Series A
$26M
Angel/Seed (2021): $6M with participation from Allen Institute for Artificial Intelligence, Vulcan Capital Management, and Madrona Venture Group
Series A (2022): $26M led by Madrona Venture Group, Microsoft, and OCV Partners
Key Investors in Ozette
Madrona Venture Group
Founded in 1995, Madrona Venture Group is a venture capitalist investment company including consumer internet, commercial software, and services.
Microsoft
Microsoft Corp. engages in the provision of developing and marketing software and hardware services. Its products include operating systems for computing devices, servers, phones and intelligent devices.
OCV Partners
OCV Partners is a venture capital firm based in Los Angeles that specializes in investing in companies with differentiated technologies in high-potential markets, particularly in sectors such as SaaS, FinTech, PropTech, and healthcare.
What's next for Ozette?
The recent major strategic investment signals a strong vote of confidence in Ozette's technology and its potential to disrupt cancer drug development. This capital infusion is expected to fuel further research and development, enhance computational capabilities, and potentially expand the company's market reach. Ozette is poised to play an increasingly vital role in the ongoing efforts to combat cancer through data-driven innovation, likely focusing on scaling its platform and forging new strategic partnerships within the pharmaceutical and biotech sectors.
See full Ozette company page
